CoChat

Toward Explainable Anticancer Compound Sensitivity Prediction via Multimodal Attention-Based Convolutional Encoders

Open access
Manica, Matteo, Oskooei, Ali, Born, Jannis, Subramanian, Vigneshwari, Sáez-Rodríguez, Julio, Rodríguez Martínez, María · 2019 · Molecular Pharmaceutics
Cited by 147

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

In line with recent advances in neural drug design and sensitivity prediction, we propose a novel architecture for interpretable prediction of anticancer compound sensitivity using a multimodal attention-based convolutional encoder. Our model is based on the three key pillars of drug sensitivity: compounds’ structure in the form of a SMILES sequence, gene expression profiles of tumors, and prior knowledge on intracellular interactions from protein–protein interaction networks. We demonstrate that our multiscale convolutional attention-based encoder significantly outperforms a baseline model trained on Morgan fingerprints and a selection of encoders based on SMILES, as well as the previously reported state-of-the-art for multimodal drug sensitivity prediction (R2 = 0.86 and RMSE = 0.89). Moreover, the explainability of our approach is demonstrated by a thorough analysis of the attention weights. We show that the attended genes significantly enrich apoptotic processes and that the drug attention is strongly correlated with a standard chemical structure similarity index. Finally, we report a case study of two receptor tyrosine kinase (RTK) inhibitors acting on a leukemia cell line, showcasing the ability of the model to focus on informative genes and submolecular regions of the two compounds. The demonstrated generalizability and the interpretability of our model testify to its potential for in silico prediction of anticancer compound efficacy on unseen cancer cells, positioning it as a valid solution for the development of personalized therapies as well as for the evaluation of candidate compounds in de novo drug design.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.molpharmaceut.9b00520

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 147

Metadata

Authors
Manica, M., Oskooei, A., Born, J., Subramanian, V., Sáez-Rodríguez, J., & Rodríguez Martínez, M.
Venue
Molecular Pharmaceutics
Published
2019-10-16
Volume
16
Issue
12
Pages
4797-4806
ISSN
  • 1543-8384 (ISSN-L)
  • 1543-8392
OpenAlex
W2942173509
Cited by
147
References
9
FWCI
12.44
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Toward Explainable Anticancer Compound Sensitivity Prediction via Multimodal Attention-Based Convolutional Encoders. https://app.cochat.ai/papers/10.1021/acs.molpharmaceut.9b00520
The paper
Manica, M., Oskooei, A., Born, J., Subramanian, V., Sáez-Rodríguez, J., & Rodríguez Martínez, M. (2019). Toward Explainable Anticancer Compound Sensitivity Prediction via Multimodal Attention-Based Convolutional Encoders. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.9b00520

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.